JP2023522630A5 - - Google Patents

Info

Publication number
JP2023522630A5
JP2023522630A5 JP2022562446A JP2022562446A JP2023522630A5 JP 2023522630 A5 JP2023522630 A5 JP 2023522630A5 JP 2022562446 A JP2022562446 A JP 2022562446A JP 2022562446 A JP2022562446 A JP 2022562446A JP 2023522630 A5 JP2023522630 A5 JP 2023522630A5
Authority
JP
Japan
Prior art keywords
antigen
amino acid
antibody
flt3
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022562446A
Other languages
English (en)
Japanese (ja)
Other versions
JP7679399B2 (ja
JP2023522630A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/059646 external-priority patent/WO2021209495A1/en
Publication of JP2023522630A publication Critical patent/JP2023522630A/ja
Publication of JP2023522630A5 publication Critical patent/JP2023522630A5/ja
Application granted granted Critical
Publication of JP7679399B2 publication Critical patent/JP7679399B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022562446A 2020-04-14 2021-04-14 抗flt3抗体及び組成物 Active JP7679399B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063009578P 2020-04-14 2020-04-14
US63/009,578 2020-04-14
PCT/EP2021/059646 WO2021209495A1 (en) 2020-04-14 2021-04-14 Anti-flt3 antibodies and compositions

Publications (3)

Publication Number Publication Date
JP2023522630A JP2023522630A (ja) 2023-05-31
JP2023522630A5 true JP2023522630A5 (cg-RX-API-DMAC7.html) 2024-04-22
JP7679399B2 JP7679399B2 (ja) 2025-05-19

Family

ID=75530015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022562446A Active JP7679399B2 (ja) 2020-04-14 2021-04-14 抗flt3抗体及び組成物

Country Status (17)

Country Link
US (2) US12252539B2 (cg-RX-API-DMAC7.html)
EP (1) EP4136114A1 (cg-RX-API-DMAC7.html)
JP (1) JP7679399B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220167331A (cg-RX-API-DMAC7.html)
CN (1) CN115715297A (cg-RX-API-DMAC7.html)
AU (1) AU2021255884A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022020683A2 (cg-RX-API-DMAC7.html)
CA (1) CA3180188A1 (cg-RX-API-DMAC7.html)
CL (1) CL2022002833A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022014520A2 (cg-RX-API-DMAC7.html)
IL (1) IL297269A (cg-RX-API-DMAC7.html)
MX (1) MX2022012919A (cg-RX-API-DMAC7.html)
PE (1) PE20230075A1 (cg-RX-API-DMAC7.html)
PH (1) PH12022552710A1 (cg-RX-API-DMAC7.html)
TW (1) TWI910146B (cg-RX-API-DMAC7.html)
WO (1) WO2021209495A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202211267B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20230075A1 (es) * 2020-04-14 2023-01-11 Servier Lab Anticuerpos anti-flt3 y composiciones
WO2024108163A2 (en) * 2022-11-18 2024-05-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Molecules that bind to cd135 polypeptides
US20260217851A1 (en) * 2022-12-22 2026-07-30 The Medical College Of Wisconsin, Inc. Compositions that Target CD138 and CD3 and Methods of Making and Using the Same
CN122055383A (zh) * 2023-07-12 2026-05-15 费诺米人工智能公司 抗cthrc1 t细胞衔接体及其使用方法
CN118924724B (zh) * 2024-07-29 2025-11-04 湖南大学 一种用于治疗神经母细胞瘤的药物组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1186301B1 (en) 1993-09-08 2006-08-16 Imclone Systems, Inc. Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
US5635388A (en) 1994-04-04 1997-06-03 Genentech, Inc. Agonist antibodies against the flk2/flt3 receptor and uses thereof
JP2002522063A (ja) 1998-08-17 2002-07-23 アブジェニックス インコーポレイテッド 増加した血清半減期を有する改変された分子の生成
WO2002066044A2 (en) 2000-10-24 2002-08-29 Immunex Corporation Method for dendritic cells based immunotherapy of tumors using combination therapy
AR071891A1 (es) 2008-05-30 2010-07-21 Imclone Llc Anticuerpos humanos anti-flt3 (receptor tirosina cinasa 3 tipo fms humano)
ES2573642T3 (es) 2009-12-23 2016-06-09 Synimmune Gmbh Anticuerpos anti-FLT3 y métodos de usar los mismos
KR20240056629A (ko) 2014-09-28 2024-04-30 더 리전트 오브 더 유니버시티 오브 캘리포니아 자극성 및 비자극성 골수성 세포의 조절
TWI829617B (zh) * 2015-07-31 2024-01-21 德商安美基研究(慕尼黑)公司 Flt3及cd3抗體構築體
EP3559038B1 (en) 2016-12-21 2022-12-14 The United States of America as represented by The Secretary Department of Health and Human Services Human monoclonal antibodies specific for flt3 and uses thereof
PE20241587A1 (es) 2017-06-02 2024-08-01 Pfizer Receptores de antigenos quimericos que se dirigen a flt3
JP7234142B2 (ja) 2017-06-02 2023-03-07 ファイザー・インク Flt3に特異的な抗体およびその使用
EP3850010A1 (en) * 2018-09-11 2021-07-21 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Improved anti-flt3 antigen binding proteins
EP3902836B1 (en) * 2018-12-18 2026-03-25 Boehringer Ingelheim IO Canada Inc. Flt3 agonist antibodies and uses thereof
PE20230075A1 (es) * 2020-04-14 2023-01-11 Servier Lab Anticuerpos anti-flt3 y composiciones

Similar Documents

Publication Publication Date Title
CN107312091B (zh) 靶向人cd19抗原的人源化单克隆抗体
CN105189562B (zh) Il-15异源二聚体蛋白及其用途
JP2024527606A5 (cg-RX-API-DMAC7.html)
JP2021511811A5 (cg-RX-API-DMAC7.html)
Chen et al. A bispecific antibody targeting HER2 and PD-L1 inhibits tumor growth with superior efficacy
JP2021530207A (ja) 二重特異性抗体及びその使用
JP2020109101A (ja) 幹細胞増強治療法
JP2024521472A5 (cg-RX-API-DMAC7.html)
US11021538B2 (en) Bispecific coupled antibody, preparation method and application thereof
CN117050165B (zh) 一种靶向猴痘病毒的抗体、其抗原结合片段及其用途
JP2022551662A (ja) Bcmaを標的とする、ヒトサルの交差反応性を有するヒト化モノクローナル抗体
JP2020527158A (ja) 多重特異性抗体混合物の生成およびその使用方法
JP2024516384A (ja) 抗cntn4特異的抗体及びその使用
WO2021115303A1 (zh) 一种抗Claudin18.2单克隆抗体、其制备方法及用途
JP2022008309A (ja) Egfl6特異的モノクローナル抗体及びそれらの使用方法
TWI910146B (zh) 抗flt3抗體及組合物
JP2024520577A5 (cg-RX-API-DMAC7.html)
CN117003897B (zh) 靶向Claudin18.2的CAR-T细胞及其用途
CN118290584A (zh) 一种包括nk细胞的药物组合物及其在制备治疗肿瘤药物中的应用
JP2023515821A5 (cg-RX-API-DMAC7.html)
CN113980133B (zh) 抗体及其在抗肿瘤中的应用
CN114685675A (zh) 双特异性抗体及其在治疗癌症中的用途
TW202019962A (zh) 標靶CD38及TGF-β的組合療法
CN118047874A (zh) 一种双特异性抗体及其与t细胞在制备治疗肿瘤药物中的应用
JP7162011B2 (ja) 癌糖ペプチドに対するモノクローナルおよびヒト化抗体